<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24474111</article-id>
      <article-id pub-id-type="pmc">3900353</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132844</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>De Sanctis-Cacchione Syndrome in a female infant - Case report<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>S&#xED;ndrome de De Sanctis-Cacchione em lactente do sexo feminino - Relato
de caso</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Caldas</surname>
            <given-names>Amadeus Lima Rocha</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rodrigues</surname>
            <given-names>Mecciene Mendes</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD - Degree in medicine from Health College of Pernambuco - Institute
of Integral Medicine (Faculdade Pernambucana de Sa&#xFA;de - Instituto de Medicina Integral
Professor Fernando Figueira - FPS-IMIP) - Recife (PE), Brazil.</aff>
      <aff id="aff02"><label>2</label> MD, PhD in Tropical Medicine from the Federal University of Pernambuco
(Universidade Federal de Pernambuco - UFPE). Dermatologist - Hospital Cancer Pernambuco
(HCP). Researcher of the Institute of Medicine Professor Fernando Figueira - EP ( IMIP )
. Preceptor of the Dermatology Service of the Hospital Otavio de Freitas - HOF.</aff>
      <author-notes>
        <corresp id="c01"><bold>MAILING ADDRESS:</bold> Mecciene Mendes Rodrigues, Rua dos Coelhos, 300 - Boa
Vista, 50070-550 - Recife - PE, Brazil. E-mail: <email>mecciene@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6</issue>
      <fpage>979</fpage>
      <lpage>981</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>6</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>The De Sanctis-Cacchione Syndrome is the rarest and most severe kind of xeroderma
pigmentosum, characterized by microcephaly, hypogonadism, neurological disorders,
mental and growth retardation, with very few cases published. The clinical findings
compatible with De Sanctis-Cacchione Syndrome and the therapeutic approach used to
treat a one year and nine months old child, with previous diagnosis of xeroderma
pigmentosum, are reported.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>A s&#xED;ndrome de de Sanctis-Cacchione &#xE9; a forma mais rara e grave do xeroderma
pigmentoso e &#xE9; caracterizada por microcefalia, hipogonadismo, altera&#xE7;&#xF5;es neurol&#xF3;gicas
e retardo mental e de crescimento, com poucos casos publicados. Relatam-se os achados
cl&#xED;nicos compat&#xED;veis com essa s&#xED;ndrome e a terap&#xEA;utica institu&#xED;da em uma lactente de
um ano e nove meses, com diagn&#xF3;stico pr&#xE9;vio de xeroderma pigmentoso.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>DNA repair</kwd>
        <kwd>DNA Repair-Deficiency Disorders</kwd>
        <kwd>Xeroderma pigmentosum</kwd>
        <kwd>Xeroderma pigmentosum group A protein</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>The De Sanctis-Cacchione Syndrome is the most rare and severe kind of xeroderma
pigmentosum (XP). It occurs when XP type A, develops with microcephaly, hypogonadism,
multiple neurological alterations and mental and growth retardation. On the other hand,
xeroderma pigmentosum is an autosomal recessive disorder associated with failure of the
DNA damage excision and repair mechanism, leading to cell hypersensitivity to
ultraviolet radiation (UVR).<sup><xref ref-type="bibr" rid="r01">1</xref>-<xref ref-type="bibr" rid="r04">4</xref></sup></p>
      <p>As a result of sunlight exposure, hyperkeratotic lesions, ephelides, telangiectasias and
solar lentigines appear on the skin. Benign tumors, pre-neoplastic and neoplastic
lesions are frequent at an early age. The most frequently found malignant histological
types are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup></p>
      <p>Neurological alterations derive from fibroblast deterioration caused by UVR. Ataxia,
hyporeflexia or areflexia may be observed, as well as alterations in motor coordination,
microcephaly, mental retardation and sensorineural deafness. Various ophthalmologic
alterations are also described.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup></p>
      <p>The treatment is primarily based on the education of the patients and their families
regarding sun exposure , in addition to wearing photoprotective clothing, glasses and
lotions. For the treatment of already established lesions, chemotherapeutic agents
(5-fluorouracil), immunomodulators (imiquimod) and retinoids (acitretin) may be
employed, depending on the location, severity and extension of the lesion. More
interventionist possibilities are radiotherapy, dermabrasion, cryotherapy and surgical
excision. The prognosis of the disease is poor.<sup><xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r07">7</xref></sup></p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A child with a year and nine months, female, born in and from &#xC1;gua Branca - Alagoas, of
mixed race, was admitted to the pediatric emergency of a tertiary hospital with
complaint of skin tumors that appeared when she was six months of age.</p>
      <p>The physical examination revealed important weight and height impairment, microcephaly,
assessed with charts proposed by the World Health Organization (WHO) and the Brazilian
Pediatric Society (SBP), with values below the 3<sup>rd</sup> percentile in every
parameter. At the neurological examination, the absence of several neuropsychomotor
developmental markers expected at her age were noted: she could not find the right words
to use, presented difficulty to walk alone, interacted little with recreational objects
and did not cooperate to get dressed.</p>
      <p>Erythema and purulent secretion were observed in the conjunctivas and skin, which
presented hypochromic and achromic spots interspersed with hyperchromic spots, mainly on
the face and limbs, in addition to hair rarefaction (<xref ref-type="fig" rid="f01">Figure 1</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>General aspect of the infant's face. Tumoral syndrome on left malar region and
hair rarefaction</p>
        </caption>
        <graphic xlink:href="abd-88-06-0979-g01"/>
      </fig>
      <p>A map of skin lesions was drawn. The outstanding locations, by suspected malignancy
aspect, were:</p>
      <p>left malar region: three keratotic lesions, of tumoral aspect and well-defined limits,
crusty surface and total area measuring 4.8 x 1.8 x 0.7 cm (<xref ref-type="fig" rid="f01">Figure 1</xref>).</p>
      <p>right malar region: tumor lesion with elevated borders and central ulceration, measuring
3.3 x 2.8 x 0.7cm (<xref ref-type="fig" rid="f02">Figure 2</xref>).</p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2:</label>
        <caption>
          <p>Lesions in right malar region and supralabial region</p>
        </caption>
        <graphic xlink:href="abd-88-06-0979-g02"/>
      </fig>
      <p>supralabial region: nodular-tumoral smooth surfaced lesion measuring 1.0 x 0.9 x 0.6 cm
(<xref ref-type="fig" rid="f02">Figure 2</xref>).</p>
      <p>cervical and thoracic dorsal region: lesions disposed as elevated, keratotic lesions,
three of them larger and two presenting central ulcerations (<xref ref-type="fig" rid="f03">Figure 3</xref>).</p>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Lesions in cervical and posterior thoracic regions, characterized by elevated
keratotic plaques and central ulceration</p>
        </caption>
        <graphic xlink:href="abd-88-06-0979-g03"/>
      </fig>
      <p>right forearm: keratotic tumoral lesion with a crusty surface and well-defined limits
(<xref ref-type="fig" rid="f04">Figure 4</xref>).</p>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Right upper limb demonstrating the general aspect of the skin of the patient, with
evidence hypochromic/ achromic, hyperchromic and lentiginous lesions, as well as
tumoral lesion of keratotic surface</p>
        </caption>
        <graphic xlink:href="abd-88-06-0979-g04"/>
      </fig>
      <p>She underwent excision and histopathological examination of the tumoral lesions and a
skin graft was performed on the two larger facial lesions. Daily local dressings with
antibiotics (neomycin) were applied. There was graft loss during the postoperative
period. After 15 days new grafting was performed on the raw areas, evolving with partial
loss of both grafts.</p>
      <p>The revaluation in the second month of the postoperative period revealed new facial
tumor growth on the scar tissue of the left malar region and increased number of
cervical lesions. As there was scarcity of donor areas for skin grafts, the removal of
all lesions was not achieved, the poor prognosis and the unsatisfactory therapeutic
result, the child was referred to the radiotherapy service for treatment of the
remaining skin lesions.</p>
      <p>The histopathological results for the excised lesions were invasive SCC and invasive SCC
with sarcomatoid area for the right and left malar regions, respectively. For the upper
lip tumor the result was atypical fibroxanthoma (AF).</p>
      <p>Despite the symptoms, a head MRI scan did not reveal alterations.</p>
      <p>The images were acquired and published with the authorization of the child's mother, by
means of an informed consent form.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Xeroderma Pigmentosum carriers present a great spectrum of clinical manifestations,
which vary within the eight existing XP groups (XPA-XPG and a type known as variant -
XPV). In 1932, De Sanctis and Cacchione reported a syndrome with classical XP
alterations type A, in addition to neurological and somatic findings.</p>
      <p>On the De Sanctis-Cacchione Syndrome the peculiarity is the early onset and severity of
lesions, which begin around the age of six months, in contrast with other XP forms,
where age at onset averages 2 years. This is justified by alteration in DNA repair
capacity after sun exposure, which depending on XP type is reduced by up to 7.5%,
compared to 100% in the control group. When she was admitted, the patient already
presented well marked tumor lesions.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup>
</p>
      <p>Hypogonadism investigation was compromised by hormonal and physiological immaturity
typical of the age. As in other reports, there was severe weight and height impairment
and microcephaly. No mention of these alterations was made in the referral letter and
data recorded in the child's pediatric follow-up card. Such evaluation might have
allowed an even earlier diagnosis.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
      <p>A more accurate neurological examination was hindered by lack of cooperation from the
child. Although the first MRI was unaltered, other studies should be carried out in the
future, since damage is progressive.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup>
</p>
      <p>Basal cell carcinoma (BCC) is the most frequent tumor. A SCC finding discloses a more
aggressive clinical picture. AF, which is rare in healthy children, is reported in XP
patients.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r10">10</xref></sup></p>
      <p>Genetic counseling is essential for the limitations to treatment and prognosis. Meetings
were held with family members for clarification about the disease and treatment, in
accessible, colloquial language, taking into consideration that the mother of the
patient was illiterate. A summary of the clinical history and treatments to which the
child was submitted was given to the child's mother.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p> Study carried out at the Institute of Integral Medicine (Instituto de Medicina
Integral Professor Fernando Figueira - IMIP) &#x2013; Recife (PE), Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="financial-disclosure">
        <p>Financial Support: none</p>
      </fn>
      <fn id="fn03" fn-type="conflict">
        <p>Conflict of Interests: none</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liy</surname>
              <given-names>MDC</given-names>
            </name>
            <name>
              <surname>Dur&#xE1;n-McKinster</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Orozco</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>S&#xE1;ez</surname>
              <given-names>MDM</given-names>
            </name>
            <name>
              <surname>Carrasco</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ruiz-Maldonado</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title xml:lang="es">Xeroderma pigmentoso con retraso psicomotor: s&#xED;ndrome de
De Sanctis Cacchione. Reporte de 2 casos de origen mexicano</article-title>
          <source>Dermatol Pediatr Lat</source>
          <year>2004</year>
          <volume>2</volume>
          <fpage>50</fpage>
          <lpage>53</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>CRD</given-names>
            </name>
            <name>
              <surname>Elias</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>ACM</given-names>
            </name>
            <name>
              <surname>Concei&#xE7;&#xE3;o</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Anestesia em paciente com Xeroderma Pigmentoso: relato
de caso</article-title>
          <source>Rev Bras Anestesiol</source>
          <year>2000</year>
          <volume>53</volume>
          <fpage>46</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="pmid">19475256</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Falc&#xF3;n Lincheta</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dortic&#xF3;s Balea</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Daniel Sim&#xF3;n</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Garbayo Ota&#xF1;o</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Xeroderma pigmentoso. S&#xED;ndrome de Sanctis Cacchione:
Presentaci&#xF3;n de 1 caso</article-title>
          <source>Rev Cubana Pediatr</source>
          <year>1998</year>
          <volume>70</volume>
          <fpage>113</fpage>
          <lpage>116</lpage>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kraemer</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Scotto</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Xeroderma Pigmentosum: cutaneous, ocular, and neurologic abnormalities
in 830 published cases</article-title>
          <source>Arch Dermatol</source>
          <year>1987</year>
          <volume>123</volume>
          <fpage>241</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="pmid">3545087</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nelson</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Fader</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Gillard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>The role of dermabrasion and chemical peels in the treatment of
patients with xeroderma pigmentosum</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1995</year>
          <volume>32</volume>
          <fpage>623</fpage>
          <lpage>626</lpage>
          <pub-id pub-id-type="pmid">7896953</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubi&#xF3; Casadevall</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gra&#xF1;a-Su&#xE1;rez</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hernandez-Yag&#xFC;e</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Vayreda Ribera</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huc Grasa</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Brunet Vidal</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Xeroderma pigmentosum: neck lymph node metastasis of a squamous cell
carcinoma of the skin treated with cetuximab</article-title>
          <source>Eur J Dermatol</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>163</fpage>
          <lpage>165</lpage>
          <pub-id pub-id-type="pmid">19106040</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prieto</surname>
              <given-names>GEA</given-names>
            </name>
            <name>
              <surname>Borroto</surname>
              <given-names>LJM</given-names>
            </name>
            <name>
              <surname>Vald&#xE9;s</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Pomares</surname>
              <given-names>IY</given-names>
            </name>
          </person-group>
          <article-title xml:lang="es">Propuesta de manejo terap&#xE9;utico en un caso de Xeroderma
pigmentosum</article-title>
          <source>Rev Cubana Invest Biom&#xE9;d</source>
          <year>1999</year>
          <volume>18</volume>
          <fpage>40</fpage>
          <lpage>42</lpage>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cleaver</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Feeney</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Tuttle</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Xeroderma Pigmentosum Group C in an Isolated Region of
Guatemala</article-title>
          <source>J Invest Dermatol</source>
          <year>2007</year>
          <volume>127</volume>
          <fpage>493</fpage>
          <lpage>496</lpage>
          <pub-id pub-id-type="pmid">16990803</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <source>WHO Multicentre Growth Reference Study Group.WHO Child Growth Standards:
Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and
body mass index-for-age: Methods and development</source>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
          <year>2006</year>
          <size units="pages">312</size>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fleury</surname>
              <given-names>LFF</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Sanches</surname>
              <given-names>JA</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Primary cutaneous sarcomas</article-title>
          <source>An Bras Dermatol</source>
          <year>2006</year>
          <volume>81</volume>
          <fpage>207</fpage>
          <lpage>221</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
